STING1 and neoplasm: Moreover, the selectively activated STING in tumor cells can stimulate and produce some chemokines and cytokines such as type I IFN, which can recruit tumor-infiltrating lymphocytes and increase the sensitivity of the initially cold tumors to ICB therapy [25].